1.
|
Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 18 to 70 Sponsor: Other Protocol IDs: 20110920A, NCT01499836
|
|
2.
|
Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 4-2007-0344, NCT01547416
|
|
3.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: Studio CERP, NCT01809106
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 2011-004609-26, NCT01793480
|
|
5.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 to 78 Sponsor: Other Protocol IDs: 4-2012-0470, NCT01703351
|
|
6.
|
Phase: No phase specified Type: Supportive care Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000459963, UCSF-03423, UCSF-H10588-24197-02, NCT00295945
|
|
7.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: 07-933, NCT00684229
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: 10-610, NCT01179308
|
|
9.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RCCS 262, NCT01488045
|
|
10.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: CRC-09-174, CAS-008-2010, NCT01544959
|
|
11.
|
Phase: No phase specified Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: AN/2012/4036, NCT01621698
|
|
12.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-186-SDR, NCT01646775
|
|
13.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 65 to 85 Sponsor: Other Protocol IDs: 4-2011-0927, NCT01665586
|